Momentum Is Strong For Adaptive Biotechnologies Corp (NASDAQ: ADPT)

Bethany Hill

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Adaptive Biotechnologies Corp is $3.10B. A total of 2.75 million shares were traded on the day, compared to an average of 2.00M shares.

In the most recent transaction, BENZENO SHARON sold 308,477 shares of ADPT for 16.91 per share on Nov 21 ’25. After the transaction, the Chief Commercial Ofc Imm Med now owns 296,791 company shares. In a previous transaction on Nov 20 ’25, BENZENO SHARON sold 297,925 shares at 16.54 per share. ADPT shares that Chief Commercial Ofc Imm Med owns now total 296,791.

Among the insiders who bought shares, SHARON BENZENO acquired of 308,837 shares on Nov 21 ’25 at a per-share price of $16.32. In another insider transaction, SHARON BENZENO bought 201,993 shares at $15.15 per share on Nov 20 ’25.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ADPT has a high of $20.65 and a low of $4.76.

As of this writing, ADPT has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.2. The company reported an EPS of -$0.23 in the last quarter

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ADPT’s latest balance sheet shows that the firm has $353.06M in Cash & Short Term Investments as of fiscal 2021. There were $111.74M in debt and $113.81M in liabilities at the time. Its Book Value Per Share was $1.34, while its Total Shareholder’s Equity was $604.10M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADPT is Buy with a score of 4.56.

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.